This whitepaper explores the transformative potential of real-world data and evidence in clinical trials, with industry experts sharing their key insights on integrating diverse data sources to enhance trial design, recruitment, and outcomes.
Clinical trial technology specialists from AstraZeneca, Parexel, Novartis and GSK examine key challenges in data quality and regulatory compliance, while outlining strategies for leveraging real-world evidence to accelerate drug development and improve patient care.
Complete the form to download the complimentary whitepaper and learn from:
- Marcus Lawrence, Director of Data Strategy at AstraZeneca
- Yuwei Zhang, Director for Real World Data and Evidence at Parexel
- Amritanshu Kumar, Real World Evidence Group Lead at Novartis
- Abda Mahmood, Associate Director for EU Vaccines Evidence at GSK